Brief: Biora Therapeutics Reports Initiation Of Phase 1 Clinical Study Of BT-600
08/01/2024 17:33
Jan 8 (Reuters) - Biora Therapeutics Inc BIOR.O :
* BIORA THERAPEUTICS ANNOUNCES INITIATION OF PHASE 1
CLINICAL
STUDY OF BT-600
* BIORA THERAPEUTICS INC - SAD/MAD STUDY TO EVALUATE SAFETY
AND
PK/PD OF BT-600, INCLUDING CONCENTRATIONS IN COLON TISSUE
Source text for Eikon: ID:nGNXbMLf9S
Further company coverage: BIOR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biora Therapeutics
See all newsBiora Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Biora Therapeutics Provides Corporate Update And Reports Third Quarter 2024 Financial Results
Biora Therapeutics Inc expected to post a loss of $3.85 a share - Earnings Preview
Biora Therapeutics Inc expected to post a loss of $3.85 a share - Earnings Preview
Brief: Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules